Read articles from Europe

November 06, 2026 by prohibitiondoesnotwork.com

The 11th European Conference on Tobacco Control, held in Istanbul from 4–6 November, has raised concerns over proposals to bring nicotine under international drug control frameworks.

Campaigners are discussing support for Palau's initiative to review nicotine under the UN Convention on Psychotropic Substances, potentially extending restrictions to smoke-free alternatives such as vapes and nicotine pouches.

Critics warn that such measures could undermine tobacco harm reduction by limiting access to lower-risk products while combustible cigarettes remain legally available. The debate highlights the importance of distinguishing nicotine dependence from smoking-related disease and assessing the potential public health consequences of further restrictions.

November 06, 2026 by westernstandard.news

Nicotine pouches are increasingly being used as a smoking cessation aid in Great Britain, with their use among adults attempting to quit nearly tripling between 2021 and 2026.

New research involving almost 8,000 adults found an association between pouch use and greater quitting success among those not also using e-cigarettes, although the overall evidence remains uncertain.

Meanwhile, Canada continues to restrict authorised nicotine pouch sales to pharmacies. The contrast raises questions about how regulation can balance consumer safety with access to potentially useful, lower-risk alternatives for adults who smoke.

November 05, 2026 by yonkerstimes.com

Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.

Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.

Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.

November 05, 2026 by yonkerstimes.com

Nicotine vaping can help adults quit smoking, but successful tobacco harm reduction involves more than simply replacing one product with another.

Clinical evidence supports e-cigarettes as a smoking cessation option, particularly for adults who struggle with traditional methods. Complete switching is important, as continued cigarette use alongside vaping may limit the potential health benefits.

Although long-term uncertainties remain, clear information about relative risk, personalised cessation support and realistic quitting plans can help smokers make informed decisions and move away from combustible tobacco.

November 05, 2026 by tobaccoasia.com

The US FDA is signalling a shift towards recognising the continuum of risk in tobacco and nicotine regulation.

At the Global Tobacco and Nicotine Forum in Lisbon, the agency outlined plans to accelerate product authorisations, reconsider its approach to flavoured e-cigarettes and improve communication about the relative risks of nicotine products.

The proposed changes also place greater emphasis on helping adults who smoke switch to lower-risk alternatives while maintaining safeguards against youth uptake. Integrating tobacco harm reduction into regulatory decisions could represent an important development in US tobacco control policy.

November 04, 2026 by clearingtheair.eu

Spain is reportedly threatening to block the EU’s proposed Tobacco Tax Directive unless minimum excise rates on rolling tobacco are reduced.

The position contrasts with Spain’s support for tighter restrictions on smoke-free nicotine products, including flavour limitations and a potential freeze on new products entering the market. Sweden has also raised objections to the proposed directive, but over taxation of lower-risk alternatives.

With EU finance ministers due to discuss the proposal on 9 November, the disagreement highlights questions about consistency in European nicotine taxation and the importance of recognising differences in product risk.

November 03, 2026 by 2firsts.com

Azerbaijan, Armenia and Georgia are taking markedly different approaches to nicotine regulation across the South Caucasus.

Azerbaijan's nationwide vape ban has raised concerns about illicit sales, while Armenia is introducing tighter technical standards and higher excise duties. Georgia has avoided sweeping vaping restrictions, despite calls for tougher controls, while offering preferential taxation to domestic cigarette manufacturers.

These contrasting policies highlight the challenges of balancing youth protection, market oversight and tobacco harm reduction. Their longer-term outcomes may offer valuable insights into how regulation affects access to lower-risk nicotine alternatives and the growth of illicit markets.

November 03, 2026 by asiantrader.biz

The UK's contrasting treatment of snus, nicotine pouches and heated tobacco raises questions about the consistency of its approach to tobacco harm reduction.

Despite Sweden's experience with smoke-free nicotine products, snus remains banned for sale in Britain, while cigarettes continue to be widely available. Consumer advocates argue that these restrictions can make it harder for smokers to find alternatives that suit their needs.

The debate highlights the importance of consumer choice, proportionate regulation and access to different lower-risk products. Smoking cessation strategies should recognise that no single alternative works for everyone.

November 03, 2026 by springer.com

A new study published in BMC Pulmonary Medicine, involving 1,519 adults across six world regions, found no clinically meaningful difference in respiratory symptom frequency between exclusive vapers and non-vapers without an established smoking history.

Although vapers reported slightly more frequent symptoms, the difference remained below the established threshold for clinical significance. The findings offer further insight into the respiratory effects of vaping, while highlighting the need for longer-term research.

For tobacco harm reduction, the distinction between statistical significance and clinically meaningful outcomes is particularly important when interpreting scientific evidence.

November 03, 2026 by planetofthevapes.co.uk

New UK rules effective from the end of October restrict the sale and promotion of vaping and nicotine products. Sales are limited to adults aged 18 or over, and adults cannot buy them on behalf of minors. Vending machines selling these and related products are prohibited, as are promotional free samples, substantial discounts and coupons. Enforcement authorities can issue fixed penalty notices for a range of offences.

The Chartered Trading Standards Institute welcomed the closure of longstanding loopholes and urged retailers to check ages, train staff and update policies. ELFBAR also welcomed the rules but called for a retail licensing system, arguing that it would enable earlier action against repeat offenders.